TOC - Erythropoietin Drugs Market Size & Trends Report

Erythropoietin Drugs Market Report by Drug Class (Biologics, Biosimilars), Product Type (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, and Others), Application (Hematology, Kidney Disorder, Cancer, and Others), End-User (Hospitals, Homecare, Specialty Clinics, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A4270

Buy Now

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Erythropoietin Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Drug Class
6.1 Biologics
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Biosimilars
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Product Type
7.1 Epoetin-alfa
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Epoetin-beta
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Darbepoetin-alfa
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Application
8.1 Hematology
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Kidney Disorder
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Cancer
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Homecare
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Specialty Clinics
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Amgen Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Biocon Limited
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Dr. Reddy’s Laboratories Ltd.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 F. Hoffmann-La Roche AG
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.5 Intas Pharmaceuticals Ltd.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Johnson & Johnson
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 LG Chem Ltd.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Pfizer Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Sun Pharmaceutical Industries Limited
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Teva Pharmaceutical Industries Ltd.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Erythropoietin Drugs Market: Major Drivers and Challenges
Figure 2: Global: Erythropoietin Drugs Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Erythropoietin Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Erythropoietin Drugs Market: Breakup by Drug Class (in %), 2024
Figure 5: Global: Erythropoietin Drugs Market: Breakup by Product Type (in %), 2024
Figure 6: Global: Erythropoietin Drugs Market: Breakup by Application (in %), 2024
Figure 7: Global: Erythropoietin Drugs Market: Breakup by End User (in %), 2024
Figure 8: Global: Erythropoietin Drugs Market: Breakup by Region (in %), 2024
Figure 9: Global: Erythropoietin Drugs (Biologics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Erythropoietin Drugs (Biologics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Erythropoietin Drugs (Biosimilars) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Erythropoietin Drugs (Biosimilars) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Erythropoietin Drugs (Epoetin-alfa) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Erythropoietin Drugs (Epoetin-alfa) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Erythropoietin Drugs (Epoetin-beta) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Erythropoietin Drugs (Epoetin-beta) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Erythropoietin Drugs (Darbepoetin-alfa) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Erythropoietin Drugs (Darbepoetin-alfa) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Erythropoietin Drugs (Other Product Types) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Erythropoietin Drugs (Other Product Types) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Erythropoietin Drugs (Hematology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Erythropoietin Drugs (Hematology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Erythropoietin Drugs (Kidney Disorder) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Erythropoietin Drugs (Kidney Disorder) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Erythropoietin Drugs (Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Erythropoietin Drugs (Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Erythropoietin Drugs (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Erythropoietin Drugs (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Erythropoietin Drugs (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Erythropoietin Drugs (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Erythropoietin Drugs (Homecare) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Erythropoietin Drugs (Homecare) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Global: Erythropoietin Drugs (Specialty Clinics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Global: Erythropoietin Drugs (Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Global: Erythropoietin Drugs (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Global: Erythropoietin Drugs (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: North America: Erythropoietin Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: North America: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: United States: Erythropoietin Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: United States: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Canada: Erythropoietin Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Canada: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Asia-Pacific: Erythropoietin Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Asia-Pacific: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: China: Erythropoietin Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: China: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Japan: Erythropoietin Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Japan: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: India: Erythropoietin Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: India: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: South Korea: Erythropoietin Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: South Korea: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: Australia: Erythropoietin Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: Australia: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Indonesia: Erythropoietin Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Indonesia: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Others: Erythropoietin Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Others: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Europe: Erythropoietin Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Europe: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Germany: Erythropoietin Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Germany: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: France: Erythropoietin Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: France: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: United Kingdom: Erythropoietin Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: United Kingdom: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Italy: Erythropoietin Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Italy: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Spain: Erythropoietin Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Spain: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Russia: Erythropoietin Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Russia: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Others: Erythropoietin Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Others: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Latin America: Erythropoietin Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Latin America: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Brazil: Erythropoietin Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Brazil: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Mexico: Erythropoietin Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Mexico: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Others: Erythropoietin Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 82: Others: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 83: Middle East and Africa: Erythropoietin Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 84: Middle East and Africa: Erythropoietin Drugs Market: Breakup by Country (in %), 2024
Figure 85: Middle East and Africa: Erythropoietin Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 86: Global: Erythropoietin Drugs Industry: SWOT Analysis
Figure 87: Global: Erythropoietin Drugs Industry: Value Chain Analysis
Figure 88: Global: Erythropoietin Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Erythropoietin Drugs Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Erythropoietin Drugs Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
Table 3: Global: Erythropoietin Drugs Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
Table 4: Global: Erythropoietin Drugs Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 5: Global: Erythropoietin Drugs Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 6: Global: Erythropoietin Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Erythropoietin Drugs Market: Competitive Structure
Table 8: Global: Erythropoietin Drugs Market: Key Players

Purchase Options New Year Sale

Inquire Before Buying

Speak to an Analyst

Request Brochure

Request Customization

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.